|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/454 | (2006.01) |
| A61P 13/12 | (2006.01) |
| (11) | Number of the document | 3675854 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18769510.1 |
| Date of filing the European patent application | 2018-08-30 | |
| (97) | Date of publication of the European application | 2020-07-08 |
| (45) | Date of publication and mention of the grant of the patent | 2025-01-22 |
| (46) | Date of publication of the claims translation | 2025-04-25 |
| (86) | Number | PCT/IB2018/056618 |
| Date | 2018-08-30 |
| (87) | Number | WO 2019/043609 |
| Date | 2019-03-07 |
| (30) | Number | Date | Country code |
| 17188870 | 2017-08-31 | EP |
| (72) |
EDER, Jörg , CH
HARRISON, Richard Alexander , GB
HARALDSSON, Boerje , CH
SCHUBART, Anna Svenja , CH
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Piperidinilindolo dariniai, skirti C3 glomerulopatijai gydyti |
| PIPERIDINYL-INDOLE DERIVATIVES FOR USE IN THE TREATMENT OF C3 GLOMERULOPATHY |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 8 | 185.00 EUR |
| 2026-08-30 |